ArticleCell reports methods2026
Toward simultaneous pseudo-space reconstruction and cell-type deconvolution of single-cell spatial transcriptome using SpaDicer.
Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward simultaneous pseudo-space reconstruction and cell-type deconvolution of single-cell spatial transcriptome using SpaDicer.Cell reports methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) offer complementary insights into tissue heterogeneity. Each modality is characterized by inherent trade-offs: scRNA-seq offers high resolution but lacks spatial context, while ST retains spatial information but compromises resolution. Here, we introduce SpaDicer, an end-to-end deep-learning framework designed to bridge these gaps by unifying pseudo-spatial reconstruction of single cells and cell-type deconvolution of ST spots. SpaDicer employs cross-domain feature disentanglement to extract domain-invariant feature encoding both cellular identity and spatial localization. An adaptive loss weighting strategy harmonizes multiple objectives across data reconstruction, cell-type deconvolution, and spatial regression tasks. We evaluated SpaDicer on two simulated datasets and on five real-world datasets covering a wide range of human tissue contexts, demonstrating consistent improvement over state-of-the-art methods in reconstructing cellular spatial localization and resolving cell-type composition. Through a unified multi-task learning framework, SpaDicer provides a powerful tool for advancing spatially informed biological discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.